| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dyslipidemia | |||||
| Coronary Heart Disease | |||||
| Atherosclerosis | |||||
| Stroke | |||||
| Diabetes | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Coronary Disease | |||||
| Dyslipidemias | |||||
| Heart Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Brain Diseases | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Lipid Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Myocardial Ischemia | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Niacin | |||||
| Atorvastatin | |||||
| Simvastatin | |||||
| Ezetimibe | |||||
| Rosuvastatin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anticholesteremic Agents | |||||
| Antilipemic Agents | |||||
| Antimetabolites | |||||
| Enzyme Inhibitors | |||||
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Kos Pharmaceuticals | |||||
|
